SCHEMBL30740933

SCHEMBL30740933

O=Cc1ccc(-c2ccccc2)cc1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 7/20 0.46
PTPN1 P18031 3/20 0.45
PTPN2 P17706 2/20 0.45
KIF11 P52732 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.41
BLM P54132 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
IP6K1 Q92551 1/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1591812 1.00 ERN1 (0.46) ERN1PTPN1PTPN2KIF11NPC1
SCHEMBL2774294 0.86 KIF11 (0.44) ERN1KIF11MEN1KMT2AKDM4E
SCHEMBL29828302 0.85 ERN1 (0.46) ERN1KIF11ESR1ESR2
SCHEMBL23480395 0.84 ALOX5AP (0.42) ERN1PTPN1MEN1KMT2ALMNA
SCHEMBL1125758 0.84 ERN1 (0.50) ERN1PTPN1PTPN2NPC1RAB9A
SCHEMBL22459322 0.84 KIF11 (0.61) ERN1KIF11MEN1KMT2AKDM4E
SCHEMBL21199864 0.83 ERN1 (0.45) ERN1KIF11ESR1ESR2
Tannin Pyrogallol SCHEMBL28665795 0.83 NFE2L2 (0.50) ERN1PTPN1PTPN2NPC1RAB9A
SCHEMBL3369299 0.83 ERN1 (0.49) ERN1MEN1KMT2AESR1ESR2
SCHEMBL4552823 0.82 TDP1 (0.48) ERN1KIF11KDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed
EP-4561975-A1 FTO INHIBITORS RPXDS Co., Ltd (CN) 2025-06-04 EP disclosed
CN-119546566-A FTO inhibitors 瑞璞鑫(苏州)生物科技有限公司 2025-02-28 CN disclosed
WO-2024022491-A1 FTO INHIBITORS RPXDS CO., LTD (CN) 2024-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 ERN1 1140/4885PTPN1 902/4885PTPN2 1574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.